Transaction · 0002124509-26-000012

Mancini Anthony

Mancini Anthony, SR, reported an open-market or private sale at Revolution Medicines, Inc. involving 587.000000 shares for an estimated $117400.00. Reported holdings after the transaction were 39765.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSR
RVMDRevolution Medicines, Inc.
Filing timeSep 28
Trade dateSep 24, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded1.45%Shares sold ÷ (holdings after + shares sold). Estimated position before: 40,352 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$201.74
Pre-filing
1mo ago +5.8%1w ago -2.4%1d ago -5.5%
Returns since
7d30d90d180d1y

RVMD price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RVMD since 2026-09-28Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002124509-26-000012
Common Stock
Transaction date
Sep 24, 2026
Filed Sep 28, 2026, 10:00 PM · 4d delay
Shares
587 sh
$200.00 per share
Estimated value
-$117k
Computed from shares × price
Holdings after
39.7k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026.

  2. F2

    Includes 39,575 restricted stock units.

  3. F3

    Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the…

Original filing · 0002124509-26-000012
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RVMD